sabatolimab
Showing 1 - 4 of 4
MDS, Leukemia, Myelomonocytic, Chronic Trial (decitabine, Spartalizumab, Sabatolimab)
Not yet recruiting
- Myelodysplastic Syndromes
- Leukemia, Myelomonocytic, Chronic
- decitabine
- +5 more
- (no location specified)
Aug 5, 2022
MDS, Acute Myeloid Leukemia Trial (Sabatolimab, Magrolimab, Azacitidine)
Not yet recruiting
- Myelodysplastic Syndromes
- Acute Myeloid Leukemia
- Sabatolimab
- +2 more
- (no location specified)
May 24, 2022
Myelodysplastic Syndrome (MDS) Trial in Worldwide (sabatolimab, azacitidine, venetoclax)
Recruiting
- Myelodysplastic Syndrome (MDS)
- sabatolimab
- +2 more
-
Duarte, California
- +14 more
May 10, 2022
Myelofibrosis Trial in Worldwide (Ruxolitinib, Siremadlin, Crizanlizumab)
Suspended
- Myelofibrosis
- Ruxolitinib
- +5 more
-
Adelaide, South Australia, Australia
- +37 more
Aug 18, 2022